does tirzepatide have less side effects than semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide Vs. Semaglutide For Weight

Retatrutide is an investigational triple hormone agonist (GLP-1, GIP, glucagon) showing promising early results for obesity and type 2 diabetes, while tirzepatide is an FDA-approved dual agonist (GLP-1, GIP) available for use today

NFE2L2 can regulate the expression of related genes by transactivation to limit oxidative damage during ferroptosis, and the NFE2L2 signaling pathway is an important defense mechanism against ferroptosis

(Removed: "respiratory system: pharmacological and clinical reappraisal") Stey C, Steurer J, Bachmann S, Medici TC, Tramer MR

Animal studies suggest that semaglutide does pass into breast milk in lactating rats

The tailwinds are real, the TAM is enormous, and the entry barriers are rising

reports personal fees from Allena, Oxthera, Sanofi, Fresenius Medical Care, Alnylam Pharmaceuticals, Advicenne, Medice and Zai, and grant support from Alnylam and Dicerna Pharmaceuticals